Home > Share Market > Stocks > Sun pharmaceuticals industries > Financial Statements > SUNPHARMA Key Financial Ratios

Sun pharmaceuticals industries Financial Statements

Sun pharmaceuticals industries Key Financial Ratios

  • Tabular Data
  • Graph
  • Consolidated
  • Standalone
Y/e 31 Mar Mar-2021 Mar-2020 Mar-2018 Mar-2017
Growth matrix (%)        
Revenue growth 2.01 24 (16) 10.90
Op profit growth 21.40 24.40 (44) 23.70
EBIT growth 30 12.70 (48) 21.50
Net profit growth (23) 74.20 (69) 53.20
Profitability ratios (%)        
OPM 25.30 21.20 21.20 31.90
EBIT margin 21.60 17 18.70 29.90
Net profit margin 8.67 11.50 8.16 22.10
RoCE 12.80 9.96 9.46 19.40
RoNW 1.58 2.25 1.44 5
RoA 1.28 1.68 1.03 3.58
Per share ratios ()        
EPS 9.52 17.50 10.70 32.70
Dividend per share 7.50 4 2 3.50
Cash EPS 3.43 7.14 2.76 23.80
Book value per share 194 189 160 153
Valuation ratios        
P/E 62.80 20.20 46.30 21.10
P/CEPS 174 49.40 180 28.90
P/B 3.09 1.87 3.10 4.50
EV/EBIDTA 15.10 11.30 18.50 14.90
Payout (%)        
Dividend payout -- -- 22.20 12.10
Tax payout (7.20) (16) (19) (13)
Liquidity ratios        
Debtor days 101 95.80 103 80.80
Inventory days 91.90 82 94.50 76.60
Creditor days (58) (62) (85) (71)
Leverage ratios        
Interest coverage (51) (18) (9.60) (24)
Net debt / equity (0.10) 0.04 0.01 (0.10)
Net debt / op. profit (0.30) 0.26 0.08 (0.50)
Cost breakup ()        
Material costs (26) (28) (28) (26)
Employee costs (20) (19) (20) (16)
Other costs (28) (31) (31) (27)

OPEN A DEMAT ACCOUNT & Get
FREE Benefits worth 10,000